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“I am just beginning to discover the diﬃculty of expressing one’s ideas on paper.  As 
long as it consists solely of descriptions it’s pretty easy; but when reasoning comes into 
play, to make a proper connection, a clearness and a moderate ﬂuency, is to me as I 
have said, a diﬃculty of which I had no idea.”
Charles Darwin near the end of the voyage of HMS Beagle
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Abstract
  Huntington’s disease (HD) is a purely genetic neurodegenerative disorder 
affecting approximately 1 in 10,000 people.  It is most commonly associated 
with excessive involuntary movement, or chorea, combined with varying 
degrees of other motor, psychiatric and cognitive disturbances.  Identification of 
the mutation in the HD gene prompted the generation of several transgenic 
mouse models.  HD is but one of a family of at least 9 triplet repeat disorders, 
all of which exhibit protein aggregation by a similar mechanism. The 
understanding of one disease is therefore of importance to the understanding of 
them all.  This thesis aims to be a comprehensive comparative study of three 
very different mouse models of HD elucidating the pathological changes that 
precede and accompany the disease process.
  The work described in this thesis presents a detailed account of a longitudinal 
study of the pathological changes that occur within the brains of founder 
generations of mice transgenic for exon 1 of the HD gene, containing a highly 
expanded CAG repeat, the R6 lines.  I have determined the intracellular sites for 
deposition and accumulation of the mutant protein huntingtin (htt), within both 
the neurons and glia of the central nervous system. The progressive 
accumulation of additional proteins within these aggregates has been described. 
The temporal evolution and spatial distribution of the neuronal intranuclear 
inclusion (NII) was determined using both immunohistochemical and 
morphometric analyses.  The cellular consequences resulting from the 
aggregation of mutant htt were also investigated. I have conducted a detailed 
morphometric analysis of neurones within the cerebral cortex, striatum and 
cerebellum throughout the period of protein deposition, until the eventual 
degeneration of these cells. The dendritic and somal changes resulting from the 
cellular disruption associated with these NII are also described.
  In a further series of experiments I have investigated the changes that occur in 
a novel model of HD, namely the conditional, doxycycline inducible double 
transgenic mouse, HD94 model.  It was interesting to find that the same 
construct when differently manipulated in two mouse lines can produce such 
contrasting symptoms and pathology. This was highlighted by the comparison 
of immunohistochemical and morphometric analyses between the HD94 and 
the R6 lines, where the pattern of mutant protein deposition was found to vary 
significantly.
  Lastly I have studied a more genetically accurate murine model of HD, the 
HD80 ‘knock-in model’.  These mice develop a pathology broadly similar to 
that of the R6 lines but markedly different to that of the HD94, and over a much 
longer time frame
  This detailed comparative analysis of the molecular and cellular pathology of 
three transgenic mouse models of HD provides new insights identifying novel 
and unique neuropathology and suggests new approaches for therapeutic 
treatments for this disease. 
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β-Gal-Beta galactosidase, reporter protein from E.coli.
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FL-Full length Hdh gene integrated into the HD80 knock-in mouse model
Fr-Fragment of the Hdh gene integrated into the HD80 knock-in model
FVB-Background strain of mice sensitive to B strain of Friend Leukaemia virus
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GGABA-γ-Aminobutyric acid
GAD-Glutamic acid decarboxylase
GFAP-Glial fibrillary acidic protein, astrocyte marker.
H
HD-Huntington’s disease
HDCRG-Huntington’s Disease Collaborative Research Group
HDF-Hereditary Disease Foundation
Hdh-Huntington’s disease gene locus










mTOR-Mammalian Target of Rapamycin protein
N




PDGF αR-Alpha receptor for platelet derived growth factor.
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PML-Promyelocytic leukemia
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